Latest Insights on PG
A Stock-Picking Mutation to Beat the Omicron ThreatThis is a company that has never made a profit. In fact, it’s never made any money at all. On top of that, analysts expect its per-share losses to double by the end of 2022. Assuming Adagio manages to generate some revenues next year — the market consensus is a minuscule $151 million — it’s already trading at almost 20 times those sales. Why? Because COVID is here to stay … and the search for a response is moving into new areas … quickly.
Two ETF Trades to Beat the Market in DecemberIt's a new month, which means two free ETF trades from Mike Carr! This time, IWY and XSD ranked at the top of his list...
To Win at Investing, Accept That There Is NO NormalAt times of extreme uncertainty, external factors drive the prices of individual stocks. Some are “a bit” predictable, like the actions of the Federal Reserve. Others are true “Black Swans” — completely unpredictable events such as Omicron. In “normal” times, on the other hand, we’re supposed to be able to predict the movement of stock prices using standard models. But what if there are no normal times? A fascinating article by a famous investment analyst convinces me that this is exactly the case.
5 Bold Predictions for 2022 and BeyondThese will be the biggest growth themes for 2022.